Literature DB >> 32727731

Standardisation of optical coherence tomography angiography nomenclature in uveitis: first survey results.

Francesco Pichi1,2, Ester Carreño Salas3, Marc D de Smet4, Vishali Gupta5, Manfred Zierhut6, Marion R Munk7,8.   

Abstract

AIM: To standardise the nomenclature for reporting optical coherence angiography (OCT-A) findings in the field of uveitis.
METHODS: Members of the International Uveitis Study Group, of the American Uveitis Society and of the Sociedad Panamericana de Infermedades Oculares that choose to participate responded to an online questionnaire about their preferred terminology when reporting on OCT-A findings in uveitis. The response of individuals with several publications on OCT-A (experts) was compared with uveitis specialists (users) who have less than five publications on the field of uveitis and OCT-A.
RESULTS: A total of 108 uveitis specialists who participated in the survey were included in the analysis. Of those, 23 were considered OCT-A 'experts'. There was an agreement in both groups for the definition of wide-field (WF)-OCT-A, and definition of neovascularisation in uveitis. Moreover, there was a difference in the responses in other areas, such as quantification of ischaemia, definition of 'large' areas of ischaemia or terms to describe decreased OCT-A signal from different causes. There was an unanimous need of 'users' and 'experts' to distinguish size of decreased OCT-A signal in uveitis, to implement a quantitative measurement of decreased flow specifically for WF-OCT-A and to use different terms for different causes of decreased OCT-A signal.
CONCLUSIONS: While there was considerable agreement in the terminology used by all uveitis experts, significant differences in terminology were noted between 'users' and 'experts'. These differences indicate the need for standardisation of nomenclature among all uveitis specialists both for the purpose of reporting and in clinical use. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Imaging; Infection; Inflammation

Year:  2020        PMID: 32727731     DOI: 10.1136/bjophthalmol-2020-316881

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

Review 1.  Use of optical coherence tomography angiography in the uveitis clinic.

Authors:  Francesco Pichi; Steven Hay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-16       Impact factor: 3.535

2.  Elevated endothelin-1 levels as risk factor for an impaired ocular blood flow measured by OCT-A in glaucoma.

Authors:  Claudia Lommatzsch; Kai Rothaus; Lasse Schopmeyer; Maria Feldmann; Dirk Bauer; Swaantje Grisanti; Carsten Heinz; Maren Kasper
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

Review 3.  Towards standardizing retinal optical coherence tomography angiography: a review.

Authors:  Danuta M Sampson; Adam M Dubis; Fred K Chen; Robert J Zawadzki; David D Sampson
Journal:  Light Sci Appl       Date:  2022-03-18       Impact factor: 17.782

4.  Comparison of Indocyanine Green Angiography and Swept-Source Wide-Field Optical Coherence Tomography Angiography in Posterior Uveitis.

Authors:  Meng Tian; Guodong Zeng; Christoph Tappeiner; Martin S Zinkernagel; Sebastian Wolf; Marion R Munk
Journal:  Front Med (Lausanne)       Date:  2022-05-02

5.  Recommendations for OCT Angiography Reporting in Retinal Vascular Disease: A Delphi Approach by International Experts.

Authors:  Marion R Munk; Amir H Kashani; Ramin Tadayoni; Jean-Francois Korobelnik; Sebastian Wolf; Francesco Pichi; Adrian Koh; Akihiro Ishibazawa; Alain Gaudric; Anat Loewenstein; Bruno Lumbroso; Daniela Ferrara; David Sarraf; David T Wong; Dimitra Skondra; Francisco J Rodriguez; Giovanni Staurenghi; Ian Pearce; Judy E Kim; K Bailey Freund; Maurizio Battaglia Parodi; Nadia K Waheed; Richard Rosen; Richard F Spaide; Shintaro Nakao; SriniVas Sadda; Stela Vujosevic; Tien Yin Wong; Toshinori Murata; Usha Chakravarthy; Yuichiro Ogura; Wolfgang Huf; Meng Tian
Journal:  Ophthalmol Retina       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.